Protagenic Therapeutics Announces Third Quarter 2021 Results and Business Update
November 16, 2021 09:58 ET | Protagenic Therapeutics, Inc.
NEW YORK, Nov. 16, 2021 (GLOBE NEWSWIRE) -- Protagenic Therapeutics, Inc. (Nasdaq: PTIX) a biopharmaceutical company focused on developing therapies to treat stress-related neurologic disorders,...
Changing the Way the World Thinks About Eating Disorders - A Free Webinar from the Brain & Behavior Research Foundation
November 21, 2019 09:00 ET | Brain & Behavior Research Foundation
New York, Nov. 21, 2019 (GLOBE NEWSWIRE) -- The Brain & Behavior Research Foundation is hosting a free webinar “Changing the Way the World Thinks About Eating Disorders” on Tuesday, December 10,...
RespireRx Pharmaceuticals Inc. Appoints James Sapirstein as Executive Vice Chairman of the Board of Directors
January 03, 2019 08:45 ET | RespireRX Pharmaceuticals Inc.
Glen Rock, N.J, Jan. 03, 2019 (GLOBE NEWSWIRE) -- RespireRx Pharmaceuticals Inc. (OTCQB: RSPI) (“RespireRx” or the “Company”), a clinical stage pharmaceutical company, focused on the development of...
RespireRx Pharmaceuticals Inc. Announces Publication of Ampakine Data:
July 25, 2018 09:00 ET | RespireRX Pharmaceuticals Inc.
Effects of Chronic Systemic Low-impact Ampakine Treatment on Neurotrophin Expression in Rat Brain Glen Rock, N.J., July 25, 2018 (GLOBE NEWSWIRE) -- RespireRx Pharmaceuticals Inc. (OTCQB: RSPI)...
Logo Blue Main.png
Neuronascent Granted Composition of Matter Patent in Europe for Oral Neuron Regenerative Technology
November 14, 2017 07:00 ET | Neuronascent, Inc.
CLARKSVILLE, Md., Nov. 14, 2017 (GLOBE NEWSWIRE) -- Neuronascent, Inc. (www.neuronascent.com), a biopharmaceutical company focused on oral therapeutics to promote neuron regeneration, today...
Nobilis Therapeutics Receives a Notice of Allowance for a Patent Covering Treatment of Psychiatric Disorders With Noble Gases
June 12, 2017 18:57 ET | Nobilis Therapeutics, Inc.
PORTLAND, Ore., June 12, 2017 (GLOBE NEWSWIRE) -- Nobilis Therapeutics announced today that the patent that it had exclusively licensed from Partners HealthCare/McLean Hospital (an affiliate of...